| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004275 | American Journal of Ophthalmology | 2009 | 8 Pages |
Abstract
Eyes with neovascular AMD treated with intravitreal bevacizumab over 2 years had significant anatomic and functional improvement compared with baseline. Further studies are necessary to confirm the long-term efficacy and safety of this treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ziad F. Bashshur, Zeina A. Haddad, Alexandre R. Schakal, Rola F. Jaafar, Alain Saad, Baha' N. Noureddin,